PT - JOURNAL ARTICLE AU - Liqin Wang AU - Dinah Foer AU - Erin MacPhaul AU - Ying-Chih Lo AU - David W. Bates AU - Li Zhou TI - Development of a Post-Acute Sequelae of COVID-19 (PASC) Symptom Lexicon Using Electronic Health Record Clinical Notes AID - 10.1101/2021.07.29.21261260 DP - 2021 Jan 01 TA - medRxiv PG - 2021.07.29.21261260 4099 - http://medrxiv.org/content/early/2021/07/31/2021.07.29.21261260.short 4100 - http://medrxiv.org/content/early/2021/07/31/2021.07.29.21261260.full AB - Objective To develop a comprehensive post-acute sequelae of COVID-19 (PASC) symptom lexicon from clinical notes to support PASC symptom identification and research.Methods We identified 26,117 COVID-19 positive patients from the Mass General Brigham’s electronic health records (EHR) and extracted 328,879 clinical notes from their post-acute infection period (day 51-110 from first positive COVID-19 test). The PASC symptom lexicon incorporated Unified Medical Language System® (UMLS) Metathesaurus concepts and synonyms based on selected semantic types. The MTERMS natural language processing (NLP) tool was used to automatically extract symptoms from a development dataset. The lexicon was iteratively revised with manual chart review, keyword search, concept consolidation, and evaluation of NLP output. We assessed the comprehensiveness of the lexicon and the NLP performance using a validation dataset and reported the symptom prevalence across the entire corpus.Results The PASC symptom lexicon included 355 symptoms consolidated from 1,520 UMLS concepts. NLP achieved an averaged precision of 0.94 and an estimated recall of 0.84. Symptoms with the highest frequency included pain (43.1%), anxiety (25.8%), depression (24.0%), fatigue (23.4%), joint pain (21.0%), shortness of breath (20.8%), headache (20.0%), nausea and/or vomiting (19.9%), myalgia (19.0%), and gastroesophageal reflux (18.6%).Discussion and Conclusion PASC symptoms are diverse. A comprehensive PASC symptom lexicon can be derived using a data-driven, ontology-driven and NLP-assisted approach. By using unstructured data, this approach may improve identification and analysis of patient symptoms in the EHR, and inform prospective study design, preventative care strategies, and therapeutic interventions for patient care.Competing Interest StatementLW, DF, EM, YCL, LZ reports no disclosures. DWB reports grants and personal fees from EarlySense, personal fees from CDI Negev, equity from ValeraHealth, equity from Clew, equity from MDClone, personal fees and equity from AESOP, personal fees and equity from Feelbetter, and grants from IBM Watson Health, outside the submitted work.Funding StatementNo specific funding was received for this project. LW, EM, YCL, DWB, LZ was supported by grant NIH-NIAID R01AI150295 and AHRQ R01HS025375. DF was supported by research funding from IBM Watson (PI: Bates and Zhou) and CRICO.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was reviewed by the Mass General Brigham Human Research Committee and determined to be exempt/non-human subjects research (Protocol 2020P000816).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesLW has full access to all of the data in the study and takes responsibility of the integrity of the data and the accuracy of the data analysis. The symptom lexicon from this research work is available through GitHub. https://github.com/bylinn/Post_Acute_COVID19_Symptom_Lexicon